Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin 20% vs Crystalloid in Septic Shock
NCT06370078Recruiting
- Sponsor
- Egymedicalpedia
- Start
- Jun 2024
- Primary completion
- Nov 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of albumin (human) in septic shock (2 arms), sponsored by Egymedicalpedia. Primary endpoint: Recovery from shock at 3 hours. Started Jun 2024; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06370078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06370078.